>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>m-Methoxybenzamide

m-Methoxybenzamide (Synonyms: m-Anisamide, meta-Methoxybenzamide, NSC 28589, NSC 209527)

Catalog No.GC47693

ADP-리보실트랜스퍼라제(ADPRT) 및 PARP의 억제제인 m-메톡시벤즈아미드(3-MBA)는 고초균의 세포 분열을 억제하여 필라멘트화 및 결국 세포 용해를 유도합니다. m-Methoxybenzamide(3-MBA)는 시험관 내 식물 성장, 미세 괴경화 및 푸른 감자(Solanum tuberosum L. subsp. andigenum)의 형질전환 효율을 향상시킵니다.

Products are for research use only. Not for human use. We do not sell to patients.

m-Methoxybenzamide Chemical Structure

Cas No.: 5813-86-5

Size 가격 재고 수량
5 g
US$83.00
재고 있음
10 g
US$160.00
재고 있음
25 g
US$378.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

m-Methoxybenzamide is an inhibitor of poly(ADP-ribose) polymerase (PARP; Ki = <2 µM).1 It also inhibits human placental ADP ribosyl transferase activity by 93% when used at a concentration of 100 µM.2 m-Methoxybenzamide (100, 200, and 300 mg/kg) increases the pain threshold in the paw pinch test in rats.3

1.Purnell, M.R., and Whish, W.J.Novel inhibitors of poly(ADP-ribose) synthetaseBiochem. J.185(3)775-777(1980) 2.Burtscher, H.J., Auer, B., Klocker, H., et al.Isolation of ADP-ribosyltransferase by affinity chromatographyAnal. Biochem.152(2)285-290(1986) 3.Sanders, R., Dill, R.E., Dorris, R.L., et al.Analgesic effects of 3-methoxybenzamide in ratsJ. Pharm. Pharmacol.41(4)268-269(1989)

리뷰

Review for m-Methoxybenzamide

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for m-Methoxybenzamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.